Fundamental dimension Equity attribute | BOTYPeer $0.04540.00% Cap $86.77KP/E 0.0x QuantScore46/100 | AFOMLeader $0.00010.00% Cap $925.3KP/E 0.0x QuantScore55/100 | BYOCPeer $0.00010.00% Cap $1.68MP/E -2.6x QuantScore23/100 |
|---|---|---|---|
1. QuantScore pillars0–100 per pillar · click a ticker for the factor breakdown | |||
Technical | |||
28/100 |
71/100 |
70/100 |
Valuation Multiples, PEG & DCF upside | 67/100 | 67/100 | 0/100 |
Health Piotroski, Altman Z, leverage & liquidity | 20/100 | 27/100 | 20/100 |
Growth Revenue / earnings growth & margins | 69/100 | 57/100 | 0/100 |
Sentiment Analyst ratings, targets & revisions | — | — | — |
2. Valuation multiples & capital pricingGreen highlight = best-in-class (lowest positive multiple) |
Trailing P/E | 0.0x | 0.0x | -2.6x |
Forward P/E (next FY) | — | — | — |
EV / EBITDA (TTM) | 1.0x | 1.1x | -61.5x |
Price / Sales | 0.4x | 96.0x | — |
Price / Free Cash Flow | -0.3x | -8.1x | — |
PEG ratio | -0.00 | -0.00 | -0.03 |
3. Financial health & solvencyLatest filings |
Piotroski F-Score | 2 / 9 | 4 / 9 | 2 / 9 |
Altman Z-Score | -260.29 (Distress) | -34363.03 (Distress) | -320.69 (Distress) |
Total debt / equity | -0.31 | -0.57 | -0.61 |
Quick ratio | 0.0x | 0.0x | 0.0x |
Interest coverage | -1.0x | -0.4x | -0.2x |
4. Growth & margins trajectoryLatest fiscal year |
Revenue growth YoY | +56.8% | +7.2% | -100.0% |
Net income growth YoY | +69.6% | +168.6% | -96.0% |
Gross margin (TTM) | -34.7% | 100.0% | 0.0% |
Operating margin (FY) | -215.9% | -3018.0% | -4492850.0% |
FCF margin (FY) | -217.4% | -1188.7% | -5412500.0% |
5. Trailing price performancePrice change over period |
1M return | -35.2% | +0.0% | +9900.0% |
3M return | -50.8% | +0.0% | 0.0% |
6M return | -54.9% | +0.0% | 0.0% |
Year to date | +4535900.0% | +9900.0% | +9900.0% |
1Y return | -97.7% | +9900.0% | +0.0% |
3Y return | -98.5% | +900.0% | 0.0% |
6. DCF valuation & street consensusDCF model · analyst consensus |
DCF model fair value | $-2.71 -6081.3% premium | $-1.90 -1896656.3% premium | $-0.0002 -276.2% premium |
Wall Street consensus target | — — | — — | — — |
Consensus stance | — | — | — |